ITLN1 and diabetes mellitus: Reports have shown that the AMPK signaling pathway is activated by various factors, including omentin, adiponectin, and mitochondrial aldehyde dehydrogenase, and contributes to cardioprotection against ischemic injury31, 32, 33 and diabetes-induced myocardial dysfunction34, 35.